These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 12818621)

  • 1. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uses of poxviruses as vectors.
    Vanderplasschen A; Pastoret PP
    Curr Gene Ther; 2003 Dec; 3(6):583-95. PubMed ID: 14683453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune recognition of poxviral vaccine vectors.
    Lousberg EL; Diener KR; Brown MP; Hayball JD
    Expert Rev Vaccines; 2011 Oct; 10(10):1435-49. PubMed ID: 21988308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal poxvirus vaccines: a comprehensive review.
    Bhanuprakash V; Hosamani M; Venkatesan G; Balamurugan V; Yogisharadhya R; Singh RK
    Expert Rev Vaccines; 2012 Nov; 11(11):1355-74. PubMed ID: 23249235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
    Moss B
    Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of recombinant vaccinia-rabies vaccine in veterinary use.
    Pastoret PP; Brochier B; Languet B; Duret C; Chappuis G; Desmettre P
    Dev Biol Stand; 1996; 87():245-9. PubMed ID: 8854024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 10. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain.
    Wang Y; Kan S; Du S; Qi Y; Wang J; Liu L; Ji H; He D; Wu N; Li C; Chi B; Li X; Jin N
    Antiviral Res; 2012 Dec; 96(3):324-32. PubMed ID: 23084929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
    Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE
    Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia and other poxvirus expression vectors.
    Moss B
    Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poxvirus-based vectors as vaccine candidates.
    Tartaglia J; Pincus S; Paoletti E
    Crit Rev Immunol; 1990; 10(1):13-30. PubMed ID: 2407263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poxvirus-vectored vaccines for rabies--a review.
    Weyer J; Rupprecht CE; Nel LH
    Vaccine; 2009 Nov; 27(51):7198-201. PubMed ID: 19925953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
    Moss B
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11341-8. PubMed ID: 8876137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.